One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
SmileDirectClub logo
SmileDirectClub SDC
report update icon

Quarterly report 2023-Q2
added 05-16-2026

SmileDirectClub Financial Statements 2022-2011 | SDC

Annual Financial Statements SmileDirectClub

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

74 M 259 M 1.27 B 766 M - - - - - - - -

Shares

121 M 118 M 110 M 102 M - - - - - - - -

Historical Prices

0.61 2.19 11.6 7.48 - - - - - - - -

Net Income

-86.4 M -102 M -78.4 M -115 M -74.8 M -32.8 M - - - - - -

Revenue

471 M 638 M 657 M 750 M 423 M 146 M - - - - - -

Cost of Revenue

143 M 178 M 207 M 178 M 134 M 64 M - - - - - -

Gross Profit

328 M 460 M 450 M 572 M 289 M 81.9 M - - - - - -

Operating Income

-262 M -259 M -217 M -490 M -45.6 M -30.5 M - - - - - -

Interest Expense

1.58 M -4.31 M 878 K 142 K -15.1 M - - - - - - -

EBITDA

-188 M -189 M -161 M -463 M -36.7 M -28 M - - - - - -

Operating Expenses

- - - 1.06 B 335 M 112 M - - - - - -

General and Administrative Expenses

279 M 326 M 312 M 581 M 122 M 48.2 M - - - - - -

All numbers in USD currency

Quarterly Income Statement SmileDirectClub

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

132 M 130 M - 121 M 121 M 120 M 119 M 119 M 118 M 117 M 114 M 112 M 109 M 105 M 103 M 99.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-17.8 M -21.4 M - -21.7 M -20.3 M -22.6 M -29.3 M -27.4 M -16.9 M -28.9 M -9.73 M -12.6 M -26.8 M -29.2 M -26.2 M -88.3 M -32.4 M -20.5 M -26 M -15 M -14 M -19.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

102 M 120 M - 107 M 126 M 152 M 126 M 138 M 174 M 199 M 185 M 169 M 107 M 197 M 197 M 180 M 196 M 178 M 129 M 120 M 107 M 68.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

28.9 M 32.9 M - 32 M 34.1 M 43.1 M - 39.4 M 45.9 M 48 M - 49.8 M 48.8 M 59.8 M - 41.4 M 34.7 M 48.9 M - 35.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

72.9 M 86.9 M - 74.8 M 91.7 M 109 M 81.9 M 98.3 M 128 M 152 M 136 M 119 M 58.3 M 137 M 143 M 139 M 161 M 129 M 90.8 M 83.7 M 73.8 M 40.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-45 M -59.2 M - -62.3 M -55 M -71.7 M -93.2 M -85 M -53.2 M -27.8 M -19.2 M -27.8 M -74 M -96.5 M -92.2 M -382 M 685 K -16.4 M -22.8 M -3.73 M -1.64 M -17.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

223 K 1.48 M - -1.32 M -5.82 M -1.42 M - -2.7 M -130 K -912 K - 1.03 M 1.76 M -4.92 M - -421 K 37 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-29.5 M -43.3 M - -43.2 M -35.4 M -52.8 M -93.2 M -66.5 M -36.5 M -11.4 M 37.2 M -13.7 M -60.1 M -85 M -64.9 M -376 M 5.75 M -11.7 M -13.9 M -1.5 M -1.64 M -17.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

59.7 M 65.2 M - 75.5 M 72.3 M 70.8 M - 85.7 M 85 M 81.1 M - 74.1 M 68.7 M 91 M - 390 M 47 M 49.5 M - 30.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements SmileDirectClub SDC
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting SmileDirectClub plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
- 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 9.38 0.21 % $ 371 M curacaoCuracao
TransMedics Group TransMedics Group
TMDX
$ 70.78 1.32 % $ 2.41 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 10.46 1.37 % $ 1.57 B usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 54.8 1.69 % $ 8.32 B usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 104.89 0.19 % $ 183 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 4.11 34.31 % $ 256 M usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Electromed Electromed
ELMD
$ 27.42 0.07 % $ 227 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 59.18 0.15 % $ 1.75 B costa-ricaCosta-rica
Venus Concept Venus Concept
VERO
- - $ 726 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 5.15 0.57 % $ 3.47 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 77.58 0.01 % $ 4.23 B britainBritain
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
LENSAR LENSAR
LNSR
$ 5.8 1.0 % $ 69.4 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.78 3.93 % $ 72.4 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.16 3.22 % $ 19.6 M usaUSA
Zynex Zynex
ZYXI
- - $ 21.1 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Align Technology Align Technology
ALGN
$ 147.31 0.83 % $ 10.7 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.55 0.39 % $ 105 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 44.39 0.53 % $ 65.7 B usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 353.7 0.71 % $ 9.64 B usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.07 4.33 % $ 257 M usaUSA